1. Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA, 61801;; 2. Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA, 61801.
1. Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA, 61801;
Theranostics. 2016 Jun 15;6(9):1336-52. doi: 10.7150/thno.15464. eCollection 2016.
Liposomes are nanocarriers comprised of lipid bilayers encapsulating an aqueous core. The ability of liposomes to encapsulate a wide variety of diagnostic and therapeutic agents has led to significant interest in utilizing liposomes as nanocarriers for theranostic applications. In this review, we highlight recent progress in developing liposomes as nanocarriers for a) diagnostic applications to detect proteins, DNA, and small molecule targets using fluorescence, magnetic resonance, ultrasound, and nuclear imaging; b) therapeutic applications based on small molecule-based therapy, gene therapy and immunotherapy; and c) theranostic applications for simultaneous detection and treatment of heavy metal toxicity and cancers. In addition, we summarize recent studies towards understanding of interactions between liposomes and biological components. Finally, perspectives on future directions in advancing the field for clinical translations are also discussed.
脂质体是由脂质双层组成的纳米载体,包裹着水相核心。脂质体能够包裹各种诊断和治疗药物,这使得人们对利用脂质体作为治疗诊断应用的纳米载体产生了浓厚的兴趣。在这篇综述中,我们强调了最近在开发脂质体作为纳米载体方面的进展,包括:a)用于荧光、磁共振、超声和核成像等检测蛋白质、DNA 和小分子靶标的诊断应用;b)基于小分子治疗、基因治疗和免疫治疗的治疗应用;c)用于同时检测和治疗重金属毒性和癌症的治疗诊断应用。此外,我们总结了最近关于脂质体与生物成分相互作用的研究。最后,还讨论了推进该领域临床转化的未来方向的观点。